Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip E Shaheen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Investigation|September 20, 2006
Targeted therapy for renal cell carcinoma: a new therapeutic paradigmPhilip E Shaheen, Ronald M Bukowski
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for renal cell carcinomaPhilip E Shaheen, Ronald M Bukowski
Clinical Genitourinary Cancer|July 25, 2006
Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reportsPhilip E Shaheen, Brian I Rini, Ronald M Bukowski
Clinical Orthopaedics and Related Research|April 20, 2002
Extensor hallucis longus innervation: an anatomic studyHossein Elgafy, Nabil A Ebraheim, Philip E Shaheen, et al.
Journal of Pain and Symptom Management|September 9, 2009
Opioid equianalgesic tables: are they all equally dangerous?Philip E Shaheen, Declan Walsh, Wael Lasheen, et al.
Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.
The American Journal of Hospice & Palliative Care|July 3, 2007
The business of palliative medicine - part 5: service utilization in a comprehensive integrated programBassam Estfan, Mellar P Davis, Declan Walsh, et al.
Journal of Pain and Symptom Management|April 24, 2010
Errors in opioid prescribing: a prospective survey in cancer painPhilip E Shaheen, Susan B Legrand, Declan Walsh, et al.
Cancer|September 20, 2006
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinomaRevathi Suppiah, Philip E Shaheen, Paul Elson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Investigation|September 20, 2006
Targeted therapy for renal cell carcinoma: a new therapeutic paradigmPhilip E Shaheen, Ronald M Bukowski
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for renal cell carcinomaPhilip E Shaheen, Ronald M Bukowski
Clinical Genitourinary Cancer|July 25, 2006
Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reportsPhilip E Shaheen, Brian I Rini, Ronald M Bukowski
Clinical Orthopaedics and Related Research|April 20, 2002
Extensor hallucis longus innervation: an anatomic studyHossein Elgafy, Nabil A Ebraheim, Philip E Shaheen, et al.
Journal of Pain and Symptom Management|September 9, 2009
Opioid equianalgesic tables: are they all equally dangerous?Philip E Shaheen, Declan Walsh, Wael Lasheen, et al.
Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.
The American Journal of Hospice & Palliative Care|July 3, 2007
The business of palliative medicine - part 5: service utilization in a comprehensive integrated programBassam Estfan, Mellar P Davis, Declan Walsh, et al.
Journal of Pain and Symptom Management|April 24, 2010
Errors in opioid prescribing: a prospective survey in cancer painPhilip E Shaheen, Susan B Legrand, Declan Walsh, et al.
Cancer|September 20, 2006
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinomaRevathi Suppiah, Philip E Shaheen, Paul Elson, et al.
Pageof 1